Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Current Progress on Central Cholinergic Receptors as Therapeutic Targets for Alzheimer's Disease
Kushagra Nagori, Madhulika Pradhan, Mukesh Kumar Sharma, et al.
Current Alzheimer Research (2024) Vol. 21, Iss. 1, pp. 50-68
Closed Access | Times Cited: 9

Showing 9 citing articles:

Role of Glial Cells and Receptors in Schizophrenia Pathogenesis
Yousef Tizabi, Marta C. Antonelli, Daniela Tizabi, et al.
Neurochemical Research (2025) Vol. 50, Iss. 2
Closed Access
Donepezil-Based Rational Design of N-Substituted Quinazolinthioacetamide Candidates as Potential Acetylcholine Esterase Inhibitors for the Treatment of Alzheimer’s Disease: In vitro and In vivo Studies
Ahmed A. Al‐Karmalawy, Ahmed F. Mohamed, Heba Nasr Shalaby, et al.
RSC Medicinal Chemistry (2025)
Closed Access
Pioglitazone improves learning and memory in a rat model of cholinergic dysfunction induced by scopolamine, the roles of oxidative stress and neuroinflammation
Arezoo Rajabian, Zahra Kioumarsi Darbandi, Mahdieh Aliyari, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Lancao decoction alleviates Alzheimer’s disease: depending on activating CaMKII to protect neuronal refunction by reducing β-amyloid in the hippocampus
Lei Wu, Yan Sun, Lingang Zhao, et al.
Journal of Ethnopharmacology (2025), pp. 119619-119619
Closed Access
The Role of α7-Nicotinic Acetylcholine Receptors in the Pathophysiology and Treatment of Parkinson’s Disease
Eslam El Nebrisi, Yosra Lozon, Murat Öz
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 3210-3210
Open Access
Ethyl gallate ameliorates diabetes-induced Alzheimer's disease-like phenotype in rats via activation of α7 nicotinic receptors and mitigation of oxidative stress
Kushagra Nagori, Madhulika Pradhan, Kartik T. Nakhate
Biochemical and Biophysical Research Communications (2024) Vol. 737, pp. 150925-150925
Closed Access | Times Cited: 3
Research progress of cell senescence in Alzheimer's disease: mechanisms and therapy
Jingwen Cai, Lin Yang, Yuewei Xu, et al.
European Journal of Pharmacology (2025), pp. 177697-177697
Closed Access
Innovative strategies for overcoming blood-brain barrier challenges in Alzheimer’s disease: A focus on green-synthesized metallic nanoparticles
Kushagra Nagori, Kartik T. Nakhate, Krishna Yadav, et al.
Inorganic Chemistry Communications (2024), pp. 113604-113604
Closed Access | Times Cited: 1
Drive My CAR-AD Research here, there and Everywhere
J. M. Górriz
Current Alzheimer Research (2024) Vol. 21, Iss. 1, pp. 1-2
Closed Access
New Insights into the Development of Donepezil-Based Hybrid and Natural Molecules as Multi-Target Drug Agents for Alzheimer’s Disease Treatment
Violina T. Angelova, Boris Petrov Stoyanov, Rumyana Simeonova
Molecules (2024) Vol. 29, Iss. 22, pp. 5314-5314
Open Access
Page 1

Scroll to top